Megan Cumerlato Managing Editor

Julie Rust (till March 2015)

Internal Medicine Topic Advisory Group

Feedback on IM TAG progress from Managing Editor

perspective

Internal Medicine TAGChair: Prof. Em. Naoko Tajima (JP)Co-chair: Dr. Rodney Franklin (UK)

Cardiovascular

Hepatobiliary

Endocrinology

Nephrology

Gastroenterology

Respiratory

Haematology

Rheumatology

Working Group Chairs ManagingEditor

Cardiovascular B. Gersh (USA)R. Franklin (UK)

T. Kohro

Endocrinology &Metabolism

A. Shimatsu (JP)E. Gregg (USA)

K. Waki

Gastroenterology P. Malfertheiner (FRG)S. Miura (JP)

J. Akiyama

Hematology W. Fibbe (Netherland)S. Okamoto (JP)

-

Hepatobiliary G. Farrell (AUS) T. TomiyaNephrology G. Becker (AUS)

K. Iseki (JP)Y. Ubara

Respiratory H. Takizawa (JP) T. SuzukiRheumatology J. Kay (USA)

M. Harigai (JP)M. Kihara

Structure of Working Groups

◦ Review of JLMMs shoreline and specialty linearization proposals by each WG for WHO.

◦ Continual code hierarchy review with updates to some areas.

◦ Definitions completed for many areas with work ongoing for content model attributes

◦ Liaison with external TAGs as necessary, i.e. Paediatric, GURM and within the IM TAG.

◦ Continued good support from external experts and societies

Achievements since Dec 2014

Impact of restructure of Infectious diseases chapter following Taskforce meeting in September 2015

Understanding the application of code extensions and clustering

Time frame for completion of proposals currently on ICD-11 Browser platform Role of ‘horizontal TAGs’ and ‘vertical TAGs’ in

completion of code hierarchy Completion of other attributes in the content

model by IM TAG WGs

Concerns – General

Cardiovascular WG◦ ‘Congenital anomaly of heart and great vessels

and related acquired abnormalities’ Minor code structure revision Continued entry of definitions ratified by WG and the

International Society for Nomenclature of Paediatric and Congenital Heart Disease (ISNPCHD) Further work needed on adult cardiology definitions

Content model review of inclusion terms - ongoing

IM TAG ME proposal submissions

Endocrinology WG◦ Continued liaison with GURM and Paediatric TAGs

regarding proposed code hierarchy changes for Adrenogenital disorders.

◦ Further discussion proposed with Nutritional WG regarding overlap areas e.g. Marasmus in adults, Thinness, Morbid obesity

◦ Ongoing discussions regarding code hierarchy for Diabetes mellitus Liaison with Nephrology WG Topic of discussion at September 2015 Taskforce

meeting with resolutions proposed.

IM TAG ME proposal submissions cont.

Gastroenterology WG◦ Liaison with Paediatric TAG Managing Editor

regarding classification issues relating to Symptoms, findings and clinical forms of the digestive system.

◦ Revised definitions added to platform

Hepatobiliary WG◦ Revised definitions added to platform and minor

code hierarchy changes regarding double parenting of some concepts.

IM TAG ME proposal submissions cont.

Haematology WG◦ WHO, ICD Office and WG chairs finalised and

implemented changes to code hierarchy – great achievement

◦ Discussion with Paediatric TAG Managing Editor regarding ‘Symptoms, signs, clinical forms, and abnormal clinical and laboratory findings’ relating to the blood inclusions terms (classification issue)

Nephrology WG◦ Discussion with Endocrine WG regarding overlap

areas: Diabetes mellitus with nephropathy Albuminuria Acute kidney injury

IM TAG ME proposal submissions cont.

Respiratory WG◦ Discussion with Allergy TAG and Paediatric TAG

with minor changes proposed to: Asthma Certain diseases of the respiratory system

Inclusion term review

Rheumatology WG◦ Discussion with Paediatric TAG Managing Editor

regarding previously proposed extension codes for Juvenile idiopathic arthritis

◦ Parenting issues – Skin chapter

IM TAG ME proposal submissions cont.

Completion of content model – inclusion/exclusion terms - issues regarding old ICD-10 index entry import

Decision on proposals already submitted to platform

Taskforce resolutions implementation◦ Diabetes mellitus◦ Infectious chapter

Field trials/Peer review

Challenges ahead – IM TAG/WHO